Assyro AI

Orange Book product · Brand (NDA)

TWIRLA

ETHINYL ESTRADIOL; LEVONORGESTREL

Brand (NDA)NDA 204017RX AGILE

At a glance

Feb 14, 2020

Approved

Brand (NDA)

Application

Not listed

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Feb 14, 2020

    6 yr 5 mo ago

  2. Today

  3. Patent 8747888 expires

    Listed drug product patent expiration.

    Jul 10, 2028

    in 2 yr 1 mo

  4. Patent 9050348 expires

    Listed drug product patent expiration.

    Jul 10, 2028

    in 2 yr 1 mo

  5. Patent 8246978 expires

    Listed drug product patent expiration.

    Aug 26, 2028

    in 2 yr 3 mo

Pharmaceutical detail

Active ingredient

ETHINYL ESTRADIOL; LEVONORGESTREL

Strength

0.03MG/24HR;0.12MG/24HR

Dosage form

SYSTEM

Route

TRANSDERMAL

TE code

Not listed

Application

NDA 204017

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8747888Jul 10, 2028in 2 yr 1 mo
Product
9050348Jul 10, 2028in 2 yr 1 mo
Product
8246978Aug 26, 2028in 2 yr 3 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.